Thomas R. Sutter - Publications

The University of Memphis, Memphis, TN, United States 
Molecular Biology, Cell Biology, Microbiology Biology

43 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Sutter CH, Olesen KM, Bhuju J, Guo Z, Sutter TR. The AHR regulates metabolic reprogramming to promote SIRT1-dependent keratinocyte differentiation. The Journal of Investigative Dermatology. PMID 30393078 DOI: 10.1016/j.jid.2018.10.019  0.56
2018 Slominski AT, Kim TK, Janjetovic Z, Brożyna AA, Żmijewski MA, Xu H, Sutter TR, Tuckey RC, Jetten AM, Crossman DK. Differential and Overlapping Effects of 20,23(OH)₂D3 and 1,25(OH)₂D3 on Gene Expression in Human Epidermal Keratinocytes: Identification of AhR as an Alternative Receptor for 20,23(OH)₂D3. International Journal of Molecular Sciences. 19. PMID 30297679 DOI: 10.3390/ijms19103072  0.56
2018 Wible RS, Ramanathan C, Sutter CH, Olesen KM, Kensler TW, Liu AC, Sutter TR. NRF2 regulates core and stabilizing circadian clock loops, coupling redox and timekeeping in. Elife. 7. PMID 29481323 DOI: 10.7554/eLife.31656  0.56
2018 Wible RS, Tran QT, Fathima S, Sutter CH, Kensler TW, Sutter TR. Pharmacogenomics of chemically distinct classes of Keap1-Nrf2 activators identify common and unique gene, protein, and pathway responses in vivo. Molecular Pharmacology. PMID 29367259 DOI: 10.1124/mol.117.110262  0.56
2017 Wible RS, Sutter TR. Soft Cysteine Signaling Network: the functional significance of cysteine in protein function and the soft acid/base thiol chemistry that facilitates cysteine modification. Chemical Research in Toxicology. PMID 28122179 DOI: 10.1021/acs.chemrestox.6b00428  0.56
2016 Campion CM, Leon Carrion S, Mamidanna G, Sutter CH, Sutter TR, Cole JA. Role of EGF receptor ligands in TCDD-induced EGFR down-regulation and cellular proliferation. Chemico-Biological Interactions. PMID 27117977 DOI: 10.1016/j.cbi.2016.04.031  0.56
2014 Muenyi CS, Carrion SL, Jones LA, Kennedy LH, Slominski AT, Sutter CH, Sutter TR. Effects of in utero exposure of C57BL/6J mice to 2,3,7,8-tetrachlorodibenzo-p-dioxin on epidermal permeability barrier development and function. Environmental Health Perspectives. 122: 1052-8. PMID 24904982 DOI: 10.1289/ehp.1308045  0.56
2014 Johnson NM, Egner PA, Baxter VK, Sporn MB, Wible RS, Sutter TR, Groopman JD, Kensler TW, Roebuck BD. Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold. Cancer Prevention Research (Philadelphia, Pa.). 7: 658-65. PMID 24662598 DOI: 10.1158/1940-6207.CAPR-13-0430  0.56
2014 Krushkal J, Murphy LE, Palmer FB, Graff JC, Sutter TR, Mozhui K, Hovinga CA, Thomas F, Park V, Tylavsky FA, Adkins RM. Epigenetic analysis of neurocognitive development at 1 year of age in a community-based pregnancy cohort. Behavior Genetics. 44: 113-25. PMID 24452678 DOI: 10.1007/s10519-014-9641-2  0.56
2014 Leon Carrion S, Sutter CH, Sutter TR. Combined treatment with sodium butyrate and PD153035 enhances keratinocyte differentiation. Experimental Dermatology. 23: 211-4. PMID 24451036 DOI: 10.1111/exd.12333  0.56
2013 Kennedy LH, Sutter CH, Leon Carrion S, Tran QT, Bodreddigari S, Kensicki E, Mohney RP, Sutter TR. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated production of reactive oxygen species is an essential step in the mechanism of action to accelerate human keratinocyte differentiation. Toxicological Sciences : An Official Journal of the Society of Toxicology. 132: 235-49. PMID 23152189 DOI: 10.1093/toxsci/kfs325  0.56
2012 Tran QT, Kennedy LH, Leon Carrion S, Bodreddigari S, Goodwin SB, Sutter CH, Sutter TR. EGFR regulation of epidermal barrier function. Physiological Genomics. 44: 455-69. PMID 22395315 DOI: 10.1152/physiolgenomics.00176.2011  0.56
2011 Sutter CH, Bodreddigari S, Campion C, Wible RS, Sutter TR. 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases the expression of genes in the human epidermal differentiation complex and accelerates epidermal barrier formation. Toxicological Sciences : An Official Journal of the Society of Toxicology. 124: 128-37. PMID 21835898 DOI: 10.1093/toxsci/kfr205  0.56
2011 Cashion AK, Umberger RA, Goodwin SB, Sutter TR. Collection and storage of human blood and adipose for genomic analysis of clinical samples. Research in Nursing & Health. 34: 408-18. PMID 21812005 DOI: 10.1002/nur.20448  0.56
2011 Ouyang X, Tran QT, Goodwin S, Wible RS, Sutter CH, Sutter TR. Yap1 activation by H2O2 or thiol-reactive chemicals elicits distinct adaptive gene responses. Free Radical Biology & Medicine. 50: 1-13. PMID 20971184 DOI: 10.1016/j.freeradbiomed.2010.10.697  0.56
2010 Sutter CH, Bodreddigari S, Sutter TR, Carlson EA, Silkworth JB. Analysis of the CYP1A1 mRNA dose-response in human keratinocytes indicates that relative potencies of dioxins, furans, and PCBs are species and congener specific. Toxicological Sciences : An Official Journal of the Society of Toxicology. 118: 704-15. PMID 20819910 DOI: 10.1093/toxsci/kfq262  0.56
2009 Overall RW, Kempermann G, Peirce J, Lu L, Goldowitz D, Gage FH, Goodwin S, Smit AB, Airey DC, Rosen GD, Schalkwyk LC, Sutter TR, Nowakowski RS, Whatley S, Williams RW. Genetics of the hippocampal transcriptome in mouse: a systematic survey and online neurogenomics resource. Frontiers in Neuroscience. 3: 55. PMID 20582282 DOI: 10.3389/neuro.15.003.2009  0.56
2009 Carlson EA, McCulloch C, Koganti A, Goodwin SB, Sutter TR, Silkworth JB. Divergent transcriptomic responses to aryl hydrocarbon receptor agonists between rat and human primary hepatocytes. Toxicological Sciences : An Official Journal of the Society of Toxicology. 112: 257-72. PMID 19692669 DOI: 10.1093/toxsci/kfp200  0.56
2009 Yates MS, Tran QT, Dolan PM, Osburn WO, Shin S, McCulloch CC, Silkworth JB, Taguchi K, Yamamoto M, Williams CR, Liby KT, Sporn MB, Sutter TR, Kensler TW. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. Carcinogenesis. 30: 1024-31. PMID 19386581 DOI: 10.1093/carcin/bgp100  0.56
2009 Sutter CH, Yin H, Li Y, Mammen JS, Bodreddigari S, Stevens G, Cole JA, Sutter TR. EGF receptor signaling blocks aryl hydrocarbon receptor-mediated transcription and cell differentiation in human epidermal keratinocytes. Proceedings of the National Academy of Sciences of the United States of America. 106: 4266-71. PMID 19255421 DOI: 10.1073/pnas.0900874106  0.56
2009 Phan V, Olusegun George E, Tran QT, Goodwin S, Bodreddigari S, Sutter TR. Analyzing microarray data with transitive directed acyclic graphs. Journal of Bioinformatics and Computational Biology. 7: 135-56. PMID 19226664 DOI: 10.1142/S0219720009003972  0.56
2009 Roebuck BD, Johnson DN, Sutter CH, Egner PA, Scholl PF, Friesen MD, Baumgartner KJ, Ware NM, Bodreddigari S, Groopman JD, Kensler TW, Sutter TR. Transgenic expression of aflatoxin aldehyde reductase (AKR7A1) modulates aflatoxin B1 metabolism but not hepatic carcinogenesis in the rat. Toxicological Sciences : An Official Journal of the Society of Toxicology. 109: 41-9. PMID 19168568 DOI: 10.1093/toxsci/kfp003  0.56
2009 Tran QT, Xu L, Phan V, Goodwin SB, Rahman M, Jin VX, Sutter CH, Roebuck BD, Kensler TW, George EO, Sutter TR. Chemical genomics of cancer chemopreventive dithiolethiones. Carcinogenesis. 30: 480-6. PMID 19126641 DOI: 10.1093/carcin/bgn292  0.56
2008 Bodreddigari S, Jones LK, Egner PA, Groopman JD, Sutter CH, Roebuck BD, Guengerich FP, Kensler TW, Sutter TR. Protection against aflatoxin B1-induced cytotoxicity by expression of the cloned aflatoxin B1-aldehyde reductases rat AKR7A1 and human AKR7A3. Chemical Research in Toxicology. 21: 1134-42. PMID 18416522 DOI: 10.1021/tx7004458  0.56
2008 Johnson DN, Egner PA, Obrian G, Glassbrook N, Roebuck BD, Sutter TR, Payne GA, Kensler TW, Groopman JD. Quantification of urinary aflatoxin B1 dialdehyde metabolites formed by aflatoxin aldehyde reductase using isotope dilution tandem mass spectrometry. Chemical Research in Toxicology. 21: 752-60. PMID 18266327 DOI: 10.1021/tx700397n  0.56
2008 Rahman M, Lax SF, Sutter CH, Tran QT, Stevens GL, Emmert GL, Russo J, Santen RJ, Sutter TR. CYP1B1 is not a major determinant of the disposition of aromatase inhibitors in epithelial cells of invasive ductal carcinoma. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 963-70. PMID 18256205 DOI: 10.1124/dmd.107.018960  0.56
2008 Silkworth JB, Carlson EA, McCulloch C, Illouz K, Goodwin S, Sutter TR. Toxicogenomic analysis of gender, chemical, and dose effects in livers of TCDD- or aroclor 1254-exposed rats using a multifactor linear model. Toxicological Sciences : An Official Journal of the Society of Toxicology. 102: 291-309. PMID 18178546 DOI: 10.1093/toxsci/kfm313  0.56
2008 Olsen CM, Huang Y, Goodwin S, Ciobanu DC, Lu L, Sutter TR, Winder DG. Microarray analysis reveals distinctive signaling between the bed nucleus of the stria terminalis, nucleus accumbens, and dorsal striatum. Physiological Genomics. 32: 283-98. PMID 17911379 DOI: 10.1152/physiolgenomics.00224.2006  0.56
2007 Huang Y, Fernandez SV, Goodwin S, Russo PA, Russo IH, Sutter TR, Russo J. Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol. Cancer Research. 67: 11147-57. PMID 18056439 DOI: 10.1158/0008-5472.CAN-07-1371  0.56
2007 Yang XR, Pfeiffer RM, Garcia-Closas M, Rimm DL, Lissowska J, Brinton LA, Peplonska B, Hewitt SM, Cartun RW, Mandich D, Sasano H, Evans DB, Sutter TR, Sherman ME. Hormonal markers in breast cancer: Coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study Cancer Research. 67: 10608-10617. PMID 17968031 DOI: 10.1158/0008-5472.CAN-07-2142  0.56
2006 Rahman M, Hayes Sutter C, Emmert GL, Sutter TR. Regioselective 2-hydroxylation of 17beta-estradiol by rat cytochrome P4501B1. Toxicology and Applied Pharmacology. 216: 469-78. PMID 16893557 DOI: 10.1016/j.taap.2006.06.004  0.56
2006 Gaudet MM, Chanock S, Lissowska J, Berndt SI, Yang XR, Peplonska B, Brinton LA, Welch R, Yeager M, Bardin-Mikolajczak A, Sherman ME, Sutter TR, Garcia-Closas M. Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women. Pharmacogenetics and Genomics. 16: 547-53. PMID 16847423 DOI: 10.1097/01.fpc.0000215067.29342.6f  0.56
2006 Peirce JL, Li H, Wang J, Manly KF, Hitzemann RJ, Belknap JK, Rosen GD, Goodwin S, Sutter TR, Williams RW, Lu L. How replicable are mRNA expression QTL? Mammalian Genome : Official Journal of the International Mammalian Genome Society. 17: 643-56. PMID 16783644 DOI: 10.1007/s00335-005-0187-8  0.56
2006 Yates MS, Kwak MK, Egner PA, Groopman JD, Bodreddigari S, Sutter TR, Baumgartner KJ, Roebuck BD, Liby KT, Yore MM, Honda T, Gribble GW, Sporn MB, Kensler TW. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole. Cancer Research. 66: 2488-94. PMID 16489057 DOI: 10.1158/0008-5472.CAN-05-3823  0.56
2006 Sutter CH, Rahman M, Sutter TR. Uncertainties related to the assignment of a toxic equivalency factor for 1,2,3,4,6,7,8,9-octachlorodibenzo-p-dioxin. Regulatory Toxicology and Pharmacology : Rtp. 44: 219-25. PMID 16460856 DOI: 10.1016/j.yrtph.2005.12.005  0.56
2006 Karuri AR, Huang Y, Bodreddigari S, Sutter CH, Roebuck BD, Kensler TW, Sutter TR. 3H-1,2-dithiole-3-thione targets nuclear factor kappaB to block expression of inducible nitric-oxide synthase, prevents hypotension, and improves survival in endotoxemic rats. The Journal of Pharmacology and Experimental Therapeutics. 317: 61-7. PMID 16371450 DOI: 10.1124/jpet.105.096396  0.56
2006 Harrigan JA, McGarrigle BP, Sutter TR, Olson JR. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene Toxicology in Vitro. 20: 426-438. PMID 16198082 DOI: 10.1016/j.tiv.2005.08.015  0.56
2005 Mammen JS, Kleiner HE, DiGiovanni J, Sutter TR, Strickland PT. Coumarins are competitive inhibitors of cytochrome P450 1B1, with equal potency for allelic variants. Pharmacogenetics and Genomics. 15: 183-8. PMID 15861043  0.56
2004 Kim JH, Sherman ME, Curriero FC, Guengerich FP, Strickland PT, Sutter TR. Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers. Toxicology and Applied Pharmacology. 199: 210-9. PMID 15364538 DOI: 10.1016/j.taap.2003.11.015  0.56
2003 Roebuck BD, Curphey TJ, Li Y, Baumgartner KJ, Bodreddigari S, Yan J, Gange SJ, Kensler TW, Sutter TR. Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz. Carcinogenesis. 24: 1919-28. PMID 14555609 DOI: 10.1093/carcin/bgg173  0.56
2003 Mammen JS, Pittman GS, Li Y, Abou-Zahr F, Bejjani BA, Bell DA, Strickland PT, Sutter TR. Single amino acid mutations, but not common polymorphisms, decrease the activity of CYP1B1 against (-)benzo[a]pyrene-7R-trans-7,8-dihydrodiol. Carcinogenesis. 24: 1247-55. PMID 12807732 DOI: 10.1093/carcin/bgg088  0.56
2002 Sutter TR, He XR, Dimitrov P, Xu L, Narasimhan G, George EO, Sutter CH, Grubbs C, Savory R, Stephan-Gueldner M, Kreder D, Taylor MJ, Lubet R, Patterson TA, Kensler TW. Multiple comparisons model-based clustering and ternary pattern tree numerical display of gene response to treatment: procedure and application to the preclinical evaluation of chemopreventive agents. Molecular Cancer Therapeutics. 1: 1283-92. PMID 12516961  0.56
2002 Sutter CH, Qian Z, Hong YP, Mammen JS, Strickland PT, Sutter TR. Genotyping human cytochrome: P450 1B1 variants. Methods in Enzymology. 357: 53-8. PMID 12424897 DOI: 10.1016/S0076-6879(02)57665-5  0.56
Show low-probability matches.